Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Current Leases: 2023-2025

Historic Current Leases for bioAffinity Technologies (BIAF) over the last 2 years, with Sep 2025 value amounting to $136,197.

  • bioAffinity Technologies' Current Leases fell 64.88% to $136,197 in Q3 2025 from the same period last year, while for Sep 2025 it was $136,197, marking a year-over-year decrease of 64.88%. This contributed to the annual value of $395,301 for FY2024, which is 8.16% up from last year.
  • According to the latest figures from Q3 2025, bioAffinity Technologies' Current Leases is $136,197, which was down 24.27% from $179,844 recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Current Leases high stood at $403,584 for Q1 2025, and its period low was $136,197 during Q3 2025.
  • In the last 3 years, bioAffinity Technologies' Current Leases had a median value of $372,787 in 2024 and averaged $331,055.
  • The largest annual percentage gain for bioAffinity Technologies' Current Leases in the last 5 years was 8.26% (2025), contrasted with its biggest fall of 64.88% (2025).
  • Over the past 3 years, bioAffinity Technologies' Current Leases (Quarterly) stood at $365,463 in 2023, then climbed by 8.16% to $395,301 in 2024, then tumbled by 64.88% to $136,197 in 2025.
  • Its Current Leases was $136,197 in Q3 2025, compared to $179,844 in Q2 2025 and $403,584 in Q1 2025.